Figure 3
Figure 3. Serial analysis of MAGE-A1289-298–specific CD8+ T-cell responses in a patient with myeloma. The magnitude of the CTAg-specific CD8+ T-cell response was determined at several time points in patient 7 who was suffering from myeloma. The x-axis indicates the number of days from diagnosis; ----, paraprotein level; and —, MAGE-A1289-298–specific CD8+ T-cell response from the point of analysis. Treatment regimens are shown. Thal indicates thalidomide; and Dex, dexamethasone.

Serial analysis of MAGE-A1289-298–specific CD8+ T-cell responses in a patient with myeloma. The magnitude of the CTAg-specific CD8+ T-cell response was determined at several time points in patient 7 who was suffering from myeloma. The x-axis indicates the number of days from diagnosis; ----, paraprotein level; and —, MAGE-A1289-298–specific CD8+ T-cell response from the point of analysis. Treatment regimens are shown. Thal indicates thalidomide; and Dex, dexamethasone.

Close Modal

or Create an Account

Close Modal
Close Modal